Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Disorders of Hemostasis01:24

Disorders of Hemostasis

915
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
915
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

180
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
180

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating Young Children With Fractures for Child Abuse: Report From the AAP.

American family physician·2026
Same author

Resuscitation After Drowning in Children: Updated Guidelines From the AHA and AAP.

American family physician·2026
Same author

Management of Chronic Constipation: Guidelines From the American Society of Colon and Rectal Surgeons.

American family physician·2026
Same author

Management of Tinnitus: Guidelines From the VA/DoD.

American family physician·2026
Same author

Acute Migraine Treatment: Guidelines From the International Headache Society.

American family physician·2026
Same author

Management of Elevated Blood Pressure in Acute Care: Statement From the American Heart Association.

American family physician·2026
Same journal

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026
Same journal

We Care, and We Will Listen.

Primary care·2026
Same journal

Addressing Sexual Health in Primary Care.

Primary care·2026
Same journal

Diagnosis and Management of Eating Disorders in Adolescents and Young Adults.

Primary care·2026
Same journal

Management of Concomitant Mental Health Conditions in Older Adults with Cognitive Impairment.

Primary care·2026
Same journal

Nonpharmacologic Management of Insomnia Disorder in Primary Care.

Primary care·2026
查看所有相关文章

相关实验视频

Updated: Jul 4, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.0K

血栓栓塞栓性疾病 血栓塞栓性疾病

Michael J Arnold1

  • 1Department of Family Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 40814, USA.

Primary care
|January 26, 2024
PubMed
概括
此摘要是机器生成的。

静脉血栓塞栓症 (VTE),包括深静脉血栓症和肺栓塞,从轻度到严重程度. 立方体治疗可能会提供一些保护,而Well的标准指导诊断非紧急病例.

关键词:
深静脉血栓形成的原因诊断 诊断 诊断 诊断 诊断管理 管理 管理 管理预防 预防 预防主要的护理是初级保健.肺栓塞 肺栓塞 是一种肺栓塞.静脉血栓塞栓症是一种静脉血栓塞栓症.

更多相关视频

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.2K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

13.2K

相关实验视频

Last Updated: Jul 4, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.0K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.2K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

13.2K

科学领域:

  • 心脏病学 心脏病学
  • 血液学 血液学 血液学

背景情况:

  • 静脉血栓塞栓症 (VTE) 包括深静脉血栓和肺栓塞,呈现的严重程度各不相同.
  • 心血管风险因素经常与静脉瘤风险因素重叠.
  • 类固醇药物治疗可能会在一定程度上降低静脉瘤风险.

研究的目的:

  • 审查VTE的临床表现,风险因素,诊断方法和治疗策略.
  • 强调他类药物在潜在减轻VTE风险中的作用.
  • 概述用于VTE诊断的临床预测分数的使用.

主要方法:

  • 审查关于VTE的现有文献.
  • 风险因素的分析,包括心血管疾病的关联.
  • 诊断标准的评估,如威尔的标准.
  • 目前对VTE的治疗方式的总结.

主要成果:

  • 静脉动脉突发症存在于从微妙的症状到紧急情况的范围.
  • 心血管疾病和VTE之间存在共同的风险因素.
  • 立方体使用与潜在的VTE风险降低有关.
  • 韦尔的标准对指导非危及生命的静脉血栓炎的诊断测试至关重要.
  • 抗凝药治疗是静脉瘤的主要治疗方法.
  • 血栓溶解药物治疗只适用于严重的,危及生命或肢体的情况.

结论:

  • 静脉瘤治疗需要基于临床表现和风险因素的细微方法.
  • 了解重叠的风险因素和潜在的治疗益处,如他类药物,至关重要.
  • 适当的诊断策略,以临床分数为指导,确保及时和有效的治疗.